Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals.
- Joseph E. Ebinger
- Justyna Fert-Bober
- Kimia Sobhani